What does this research mean for the field?

In patients with high-grade serous ovarian cancer, tumor tissues are enriched in memory and antibody-secreting B cells, and the presence of spatially organized B-cell clusters after neoadjuvant chemotherapy correlates with better prognosis and reduced early relapse. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To characterize the phenotype, spatial distribution, and activation of B-cell subsets in the tumor microenvironment and peripheral blood of patients with high-grade serous ovarian cancer across neoadjuvant chemotherapy.

August 29, 2026Translational OncologyOpen Access

Characterization of B cell activation and spatial distribution in the tumor microenvironment of high-grade serous ovarian cancer

View Full Paper

Ask AI

Bookmark

Authors

ECEleonora CapezzaliUniversity of Udine MAMartina ArcieriUniversity of Udine STSilvia TononUniversity of Udine

Discussion

Member takes

Implication

Randomized trial reveals organized B-cell clusters and phenotypic maturation in advanced ovarian cancer after chemotherapy, suggesting localized B cells indicate improved prognosis.

Key Points

To characterize the phenotype, spatial distribution, and activation of B-cell subsets in the tumor microenvironment and peripheral blood of patients with high-grade serous ovarian cancer across neoadjuvant chemotherapy.
Translational trial (MICO trial, NCT06272240) evaluating 30 patients with FIGO stage III–IV high-grade serous ovarian cancer alongside healthy control subjects.
Blood and tumor tissue samples were collected at baseline (primary debulking surgery or laparoscopy) and at interval debulking surgery following neoadjuvant chemotherapy.
Phenotypic subsets, maturation markers, and spatial distribution were profiled using multiparametric flow cytometry and immunohistochemistry, correlated with BRCA status and survival.
Tumor-infiltrating B cells constituted 2% to 28% of tumor-infiltrating immune cells, with patient tumors showing significant enrichment in CD19+ B cells, memory B cells, and antibody-secreting cells compared to healthy controls.
Circulating CD71+ B cells were significantly elevated at baseline in patients compared to controls, and tumor-infiltrating CD21+ B cells increased following neoadjuvant chemotherapy.
Patients with favorable prognosis exhibited organized B-cell clusters in intratumoral and peritumoral regions after interval debulking surgery, whereas patients with early relapse lacked these clusters.

Cite This Study

Capezzali et al. (2026) studied this question.

synapsesocial.com/papers/6a9299ac8e5d7d1fc0c11aee https://doi.org/10.1016/j.tranon.2026.103004

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial reveals organized B-cell clusters and phenotypic maturation in advanced ovarian cancer after chemotherapy, suggesting localized B cells indicate improved prognosis.

Characterization of B cell activation and spatial distribution in the tumor microenvironment of high-grade serous ovarian cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Characterization of B cell activation and spatial distribution in the tumor microenvironment of high-grade serous ovarian cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider